|
J Biol Chem, Vol. 275, Issue 4, 2255-2258, January 28, 2000
ACCELERATED PUBLICATION
Association of Heterotrimeric Gi with the
Insulin-like Growth Factor-I Receptor
RELEASE OF G SUBUNITS UPON RECEPTOR
ACTIVATION*
Hazem
Hallak,
Andrea E. M.
Seiler,
Jaime S.
Green,
Brian
N.
Ross, and
Raphael
Rubin
From the Department of Pathology, Anatomy and Cell Biology,
Jefferson Medical College, Philadelphia, Pennsylvania 19107
 |
ABSTRACT |
The insulin-like growth factor-I receptor
(IGF-IR) is a key regulator of cell proliferation and survival.
Activation of the IGF-IR induces tyrosine autophosphorylation and the
binding of a series of adaptor molecules, thereby leading to the
activation of MAPK. It has been demonstrated that pertussis toxin,
which inactivates the Gi class of GTP-binding
proteins, inhibits IGF-I-mediated activation of MAPK, and a specific
role for G subunits in IGF-I signaling was shown. In
the present study, we have investigated the role of heterotrimeric
Gi in IGF-IR signaling in neuronal cells. Pertussis toxin
inhibited IGF-I-induced activation of MAPK in rat cerebellar granule
neurons and NG-108 neuronal cells. G i and
G subunits were associated with IGF-IR
immunoprecipitates. Similarly, in IGF-IR-null mouse embryo fibroblasts
transfected with the human IGF-IR, Gi was complexed with
the IGF-IR. G s was not associated with the IGF-IR in any
cell type. IGF-I induced the release of the G subunits
from the IGF-IR but had no effect on the association of
G i. These results demonstrate an association of
heterotrimeric Gi with the IGF-IR and identify a discrete
pool of G subunits available for downstream signaling
following stimulation with IGF-I.
 |
INTRODUCTION |
Many receptors are coupled to
heterotrimeric GTP-binding proteins
(G-proteins). Prototypic G-protein coupled receptors
(GPCRs)1 contain a seven-membrane spanning region (1).
Activated GPCRs bind to G-proteins and induce the release of
G subunits from G subunits, which
allows for the exchange of GDP for GTP on the G subunit.
Activated Gi subunits and G heterodimers
interact with numerous signaling effectors, including adenylyl cyclase,
ion channels, protein kinases, and phospholipases (2-4).
In addition to their role in fully differentiated cells, GPCRs have
been linked to mitogenesis and development (5-8). A specific role for
Gi in the induction of mitogenesis has been highlighted by
the use of pertussis toxin, which inactivates Gi by
ADP-ribosylation of the G subunit. However,
G subunits from several classes of G-proteins are not
strongly mitogenic. Rather G heterodimer subunits
activate a series of nonreceptor tyrosine kinases, which in turn
activates p21ras and extracellular
signal-regulated kinases (or MAPK). Thus, G subunits
serve to bridge intracellular signaling of classical GPCRs and
mitogenic tyrosine kinase receptors (RTKs).
Gi also appears to be involved in the mitogenic actions of
RTKs. Pertussis toxin variably inhibits the metabolic actions of insulin, both in vitro and in vivo (9-16), and
the insulin receptor may associate with Gi (17-19).
Importantly, mice with targeted knockout of Gi have defects
in insulin signaling (20). EGF-dependent signaling is also
impaired by pertussis toxin in rat hepatocytes (21-23) and other cells
(24-27).
The insulin-like growth factor-I receptor (IGF-IR), which has strong
homology to the insulin receptor, exists as an
2- 2-heterodimer and contains a
cytoplasmic tyrosine kinase domain (28, 29). Upon activation by its
ligands IGF-I and IGF-II, the IGF-IR undergoes tyrosine
autophosphorylation, after which it phosphorylates key signaling
molecules and leads to the sequential activation of ras,
raf, and MAPK. The role of Gi in signaling by
the IGF-IR is controversial. In fibroblasts, pertussis toxin inhibits
the IGF-I-induced opening of a calcium-permeable cation channel (30) and the activation of MAPK (31). In the latter study, Luttrell et
al. (31) demonstrated that MAPK activation by IGF-I was also inhibited by G subunit binding proteins. Inhibitory effects of pertussis toxin have been observed for other
IGF-I-dependent cellular effects (32-35) although not in
all cases (36-39).
Because IGF-I exerts profound proliferative and survival effects on
many cell types, including neuronal cells, we have investigated the
role of Gi in IGF-I signaling in neuronal cells. We report the specific association of Gi with the IGF-IR and
inhibition of MAPK activation by pertussis toxin. Importantly, IGF-I
stimulation induces the release of G subunits from
the IGF-IR. The findings offer a model wherein Gi
heterotrimers are constitutively associated with the IGF-IR and
identify a discrete pool of G subunits available for
IGF-IR signaling.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Antibodies against G i,
G s, G , IGF-IR domain, and
anti-phosphotyrosine (py99) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-MAPK and anti-phospho-MAPK (E10)
antibodies, horseradish peroxidase-conjugated goat anti-rabbit IgG, and
horse anti-mouse IgG antibodies and signal-enhanced chemiluminescence reagents were obtained from New England Biolabs (Beverly, MA). Pertussis toxin was purchased from Calbiochem (La Jolla, CA). Human
recombinant IGF-I was obtained from Bachem Bioscience, Inc., (King of
Prussia, PA). All other chemical and biochemicals were of the highest
purity commercially available.
Cell Lines and Culture Conditions--
Balb/c3T3 cells were
obtained from American Type Culture Collection (Manassas, VA). Mouse
embryo fibroblasts with targeted knockout of the IGF-IR
(R cells) and R cells that express human
IGF-IR (R+) cells were a gift from Dr. R. Baserga (Kimmel
Cancer Center, Thomas Jefferson University). The generation and
characterization of R and R+ cells have been
described elsewhere (40, 41). Fibroblasts were passaged in Dulbecco's
modified Eagle's medium supplemented with 10% normal calf serum and 2 mM glutamine. NG-108 neuroblastoma cells, a gift from Dr.
I. Diamond, University of California, were cultured in Dulbecco's
modified Eagle's medium containing 6% (v/v/) fetal calf serum and
supplemented with 1 µM aminopterin, 100 µM hypoxanthine, and 16 µM thymidine. Fibroblasts and NG-108
cells were cultured in serum-free medium for 18 h prior to
addition of IGF-I. Where indicated, cells were treated with pertussis
toxin for 4 h prior to the addition of IGF-I.
Rat cerebellar granule neurons were prepared from 7-day-old rat pups as
reported previously (42, 43). Briefly, cerebella were obtained from
postnatal day 7 Harlan Sprague-Dawley rat pups, cross-chopped (400 × 400 µM), and then treated with 0.025% trypsin-EDTA (including 0.01% DNase I) for 15 min, 37 °C. Cells were triturated and plated at a density of 1 × 106/cm2 on
poly-D-lysine-coated plates in Basal Medium Eagle (BME)
containing 10% fetal bovine serum, 25 mM KCl, 100 units/ml
penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. 10 µM cytosine arabinoside was added after 24 h to
inhibit nonneuronal replication. Cerebellar neurons were used after 7 days in vitro. For treatment with IGF-I, cells were washed
twice and cultured for 2 h in BME with 5 mM KCl.
Immunoprecipitations and Western Blot Analysis--
Cells were
lysed in ice-cold Triton lysis buffer (50 mM HEPES (pH
7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 0.5 mM EDTA, 10% glycerol, 1% Triton
X-100, 100 mM NaF, 2 mM
Na3VO4, 10 mM sodium
PPI, 10 mM phenylmethylsulfonyl fluoride, 500 µM AEBSF (Sigma), 150 nM aprotinin, 1 µM E-64 (Sigma), and 1 µM leupeptin). The
lysates were centrifuged at 14,000 × g for 10 min at
4 °C, and the supernatants were collected. Protein concentrations
were determined by a colorimetric assay (44). Cell lysates containing 30 µg of protein were electrophoresed in 11% denaturing
polyacrylamide gels. For immunoprecipitations, supernatants were
diluted with 1 volume of HNTG (20 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, 10 mM NaF and 2 mM Na3VO4). Equal amounts of
protein (250 µg) from each sample were immunoprecipitated using 0.4 µg/ml of antibody to either IGF-IR or G-protein subunits and were
captured using protein A-agarose beads. Immunoprecipitates were
subjected to SDS-PAGE, transferred to Immobilon-P membranes and
visualized by Western blotting. For Western blot analysis, the proteins
were transferred to Immobilon-P membranes, blocked with 3% bovine
serum albumin and probed with antibodies (1:2000 for all antibodies except 1:1000 for anti-MAPK antibodies), followed by secondary horseradish peroxidase-conjugated goat anti-rabbit IgG or horse anti-mouse IgG antibodies. Membranes were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech). The figures are scanned
images and are representative of 3-5 experiments.
 |
RESULTS |
The role of Gi in the activation of p42/p44 MAPK by
IGF-I was investigated in Balb/c 3T3 cells, rat cerebellar granule
neurons, and NG-108 neuronal cells (Fig.
1). Basal MAPK phosphorylation was
reduced by pertussis toxin in Balb/c 3T3 and NG-108 cells but not in
cerebellar granule neurons. In agreement with a previous report (31),
pertussis toxin markedly inhibited IGF-I-induced MAPK phosphorylation
in all cell types. Total MAPK content was unchanged under all
conditions. Pertussis treatment had no effect on cell viability.
Pertussis toxin inactivates both Gi and Go, but
3T3 cells lack Go. The results indicate that Gi
is at least partially required for MAPK activation by IGF-I.

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 1.
Pertussis toxin inhibits activation of MAPK
by IGF-I. Cerebellar granule neurons, NG-108 cells, or Balb/c 3T3
cells were treated with IGF-I (25 ng/ml) for 10 min in the presence or
absence of pertussis toxin (200 ng/ml). Phospho-MAPK and MAPK levels
were determined by Western blotting as described under "Experimental
Procedures."
|
|
Having established a requirement for Gi in IGF-I-induced
neuronal MAPK activation, we next examined the relationship between G i and the IGF-IR. IGF-IR was immunoprecipitated under
nondenaturing conditions and probed for G i content by
Western blot analysis with anti-G i antibody. Fig.
2 illustrates that G i is associated with the IGFR-I in both cerebellar granule cells and NG-108
cells. The IGF-IR and G i were similarly complexed in
Balb/c 3T3 cells (data not shown). G s subunits were not detected in IGF-IR immunoprecipitates from any cell type despite copious expression in total cell lysates (not shown). The
IGF-IR/G i interaction was completely disrupted when the
IGF-IR was immunoprecipitated under denaturing conditions (not shown).
IGF-I had no effect on the association of G i with the
IGF-IR. The IGF-IR was active under these experimental conditions, as
manifest by IGF-I-induced tyrosine autophosphorylation of the domain of the IGF-IR in both cell types (Fig. 2, bottom
panel).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 2.
G i subunit
associates with the IGF-IR. The IGF-IR was immunoprecipitated from
cerebellar granule neurons and NG-108 cells either before or after a
10-min treatment with IGF-I (25 ng/ml). Immunoprecipitates were probed
for G i (top), IGF-IR (middle), or
phosphotyrosine content (bottom) by Western blotting, as
described under "Experimental Procedures."
|
|
The anti-IGF-IR antibody did not cross-react with G i.
Fig. 3 demonstrates that
G i subunits were not identified using anti-IGF-IR
antibodies in mouse embryo fibroblasts with targeted knockout of the
IGF-IR (R cells). Both proteins were immunoprecipitated
by anti-IGF-IR antibody upon restoration of IGF-IR expression
(R+ cells)

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 3.
Anti-IGF-IR antibody requires IGF-IR to
immunoprecipitate G i. Lysates or
anti-IGF-IR immunoprecipitates were obtained from R (R )
or R+ (R+) cells and probed for G i
(top panels) and IGF-IR content (bottom panels)
by Western blotting.
|
|
A requirement for G subunit release in IGF-IR-induced
MAPK activation was suggested by the studies of Luttrell et al. (31). In conjunction with the observation that
G i does not dissociate from the IGF-IR in response to
IGF-I, we conjectured that IGF-I induces G subunit
release from the IGF-IR. Fig. 4
demonstrates that G subunit coimmunoprecipitates with the IGF-IR in both cerebellar granule neurons and NG-108 cells. The
amount of G subunit associated with the IGF-IR decreased dramatically in response to IGF-I. G subunit expression
within total cell lysates was identical under all conditions. Fig. 4 also demonstrates that pertussis toxin prevented the release of G subunit from the IGF-IR but had no effect on the
expression of IGF-IR or G subunit. We conclude that
heterotrimeric Gi is constitutively associated with IGF-IR
and responds to IGF-I by release of free G
subunits.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 4.
IGF-I induces the release of
G subunit from the IGF-IR complex.
IGF-IR immunoprecipitates were obtained from cerebellar granule neurons
and NG-108 cells either before or after a 10-min treatment with IGF-I
(25 ng/ml), in the presence or absence of pertussis toxin.
G subunit content within IGF-IR immunoprecipitates or
total lysates was determined by Western blotting. G
content within total lysates is also shown.
|
|
 |
DISCUSSION |
The use of pertussis toxin and  subunit binding proteins has
provided indirect evidence for an additional role of Gi in the activation of MAPK by IGF-I (31). In the current study, we extended
these findings to neuronal cell types and now provide direct evidence
for the constitutive association of heterotrimeric Gi with
the IGF-IR complex. Both G i and G
subunits co-immunoprecipitate with IGF-IR in cerebellar neurons and
NG-108 cells. Importantly, IGF-I induces the release of
G subunits from the IGF-IR complex, whereas the
association of G i with the IGF-IR is unaffected. The
current data do not allow us to determine whether G i binds directly to the IGF-IR or to another protein in the IGF-IR complex. G subunits exhibit a pleckstrin homology
domain which mediates binding to several molecules that are part of the IGF-IR signaling complex including IRS-1 and PI 3-kinase (3). However,
these interactions are unlikely to play a role in binding of
G subunits to the IGF-IR because IRS-1 and PI
3-kinase are not bound to the IGF-IR in its unactivated state.
RTKs for insulin, IGF-I and EGF, among others, contain SH2 binding
domains which anchor adaptor proteins such as IRS-1 and Shc (28, 29).
Phosphorylation of these intermediaries leads to the activation of
p21ras, MAPK, and transcriptional activation.
Both IRS-1 and Shc can independently lead to MAPK activation, although
studies in some cell types have suggested that Shc may ultimately be
more important for mitogenesis (45, 46). The IGF-IR also activates PI
3-kinase, which has diverse functions, including an anti-apoptotic role mediated by its activation of Akt (47-49). However, the relative contribution of these diverse signaling pathways to functional effects
must be studied individually. There is also ample experimental evidence
to support a role for the IGF-IR in the maintenance of the transformed
phenotype. Notably, R cells are resistant to
transformation in response to several oncogenic influences (50).
Transformation is restored upon expression of the IGF-IR. In contrast,
Leroith and co-workers have recently demonstrated that a constitutively
active mutant of G 13 can transform R cells
(51).
The role of Gi in IGF-I signaling likely varies among
different cell types. Pertussis toxin variably inhibits biological
actions of IGF-I. In 3T3 cells (30) and chondrocytes (32), pertussis toxin inhibits IGF-I-induced mobilization of intracellular calcium. Anti-G i antibodies inhibit the opening of a
calcium-permeable cation channel in response to IGF-I (30). Pertussis
toxin also inhibits the activation of human neutrophil phagocytosis
(35) and blocks IGF-I induced proliferation of myoblasts (33). By contrast, pertussis toxin failed to inhibit several
IGF-I-dependent phenomena including GTP[S] binding to rat
kidney epithelial cell membranes (36), DNA synthesis in MG-63
osteosarcoma cells (38), and IGF-I-induced human melanoma cell motility
(39). We have also noted that pertussis toxin has no effect on the
ability of IGF-I to protect cerebellar granule cells from apoptosis
induced by removal of growth factors and low extracellular potassium
(43, 52).2 Thus, as is the
case for other signaling mediators of the IGF-IR, the specific
functional role of G subunits in IGF-I signaling is
likely dependent upon cell context.
Gi may also associate with the insulin receptor.
G i2 and G (but not G i1 or
G i3) were identified in purified insulin receptor
preparations (14). In a recent study, Sanchez et al. (19)
reported that activation of the insulin receptor recruits
G i to this receptor, in a manner similar to classical GPCRs. However, this differs from our finding that G i
constitutively associates with the IGF-IR. Pertussis toxin inhibits
metabolic and mitogenic actions of insulin in a variety of cell culture models (9-16), and insulin enhances GTP binding to membranes (16, 18).
In a recent study of rat hepatoma cell membranes (19), antibodies
targeted against G i but not G o, prevented insulin-stimulated GTP binding. Similarly, anti-G i
antibodies blocks insulin-induced NADPH-dependent
generation of hydrogen peroxide in human adipocyte membranes (14).
The mechanism by which the IGF-IR induces G subunit
release is unclear. Direct tyrosine phosphorylation of
G i by the insulin receptor was suggested in studies of
phospholipid vesicles co-inserted with G i (17). However,
other data are inconsistent with the notion that G i is
phosphorylated by the insulin receptor (53-56). Thus, a pathway other
than tyrosine kinase activation may account for G
release, perhaps a configurational change induced by IGF-I. Our
preliminary studies are in agreement with this view. Although we can
detect tyrosine phosphate residues within G i by Western
blotting, IGF-I has no effect on the tyrosine phosphorylation state of
the G i subunit protein.
In conclusion, this study demonstrates the constitutive association of
Gi with the IGF-IR, and provides a mechanism for release of
an IGF-I-sensitive pool of G subunits. In cerebellar granule cells and NG-108 cells specifically, G
subunit release is required for MAPK activation. The findings highlight the potential role of G subunits in the regulation of neuronal MAPK activity, which is a key element in neuronal development and regeneration.
 |
ACKNOWLEDGEMENT |
We thank Dr. Kevin Williams for helpful discussions.
 |
FOOTNOTES |
*
This research was supported by National Institutes of Health
Grants AA09976, AA07186, and AHA9730028N.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology,
Anatomy and Cell Biology, 1020 Locust St., Rm. 233, Alumni Hall,
Philadelphia, PA 19107. Tel.: (215)503-0417; Fax: (215)955-8703; E-mail: raphael.rubin@mail.tju.edu.
2
H. Hallak, and R. Rubin, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
GPCR, G-protein
coupled receptor;
MAPK, mitogen-activated protein kinase;
RTK, tyrosine
kinase receptor;
IGF-IR, insulin-like growth factor-I receptor;
PI
3-kinase, phosphatidylinositol 3-kinase;
IRS-1, insulin receptor
substrate-1.
 |
REFERENCES |
| 1.
|
Ji, T. H.,
Grossmann, M.,
and Ji, I.
(1998)
J. Biol. Chem.
273,
17299-17302[Free Full Text]
|
| 2.
|
Gilman, A. G.
(1987)
Annu. Rev. Biochem.
56,
615-649[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Clapham, D. E.,
and Neer, E. J.
(1997)
Annu. Rev. Pharmacol. Toxicol.
37,
167-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Hamm, H. E.
(1998)
J. Biol. Chem.
273,
669-672[Free Full Text]
|
| 5.
|
van Biesen, T.,
Luttrell, L. M.,
Hawes, B. E.,
and Lefkowitz, R. J.
(1996)
Endocr. Rev.
17,
698-714[Abstract/Free Full Text]
|
| 6.
|
Gutkind, J. S.
(1998)
J. Biol. Chem.
273,
1839-1842[Free Full Text]
|
| 7.
|
Rozengurt, E.
(1998)
J. Cell. Physiol.
177,
507-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Lopez-Ilasaca, M.
(1998)
Biochem. Pharmacol.
56,
269-277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Goren, H. J.,
Northup, J. K.,
and Hollenberg, M. D.
(1985)
Can. J. Physiol. Pharmacol.
63,
1017-1022[Medline]
[Order article via Infotrieve]
|
| 10.
|
Heyworth, C. M.,
Grey, A. M.,
Wilson, S. R.,
Hanski, E.,
and Houslay, M. D.
(1986)
Biochem. J.
235,
145-149[Medline]
[Order article via Infotrieve]
|
| 11.
|
Vila, M. C.,
Milligan, G.,
Standaert, M. L.,
and Farese, R. V.
(1990)
Biochemistry
29,
8735-8740[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Curto, M.,
Piccinini, M.,
Rabbone, I.,
Mioletti, S.,
Mostert, M.,
Bruno, R.,
and Rinaudo, M. T.
(1997)
Int. J. Biochem. Cell Biol.
29,
1207-1217[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nie, L.,
Kanzaki, M.,
Shibata, H.,
and Kojima, I.
(1998)
Endocrinology
139,
179-188[Abstract/Free Full Text]
|
| 14.
|
Krieger-Brauer, H. I.,
Medda, P. K.,
and Kather, H.
(1997)
J. Biol. Chem.
272,
10135-10143[Abstract/Free Full Text]
|
| 15.
|
Butler, A. P.,
Martinez, L. A.,
and Montgomery, R. L.
(1996)
Cell Signal.
8,
475-480[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Kellerer, M.,
Obermaier-Kusser, B.,
Profrock, A.,
Schleicher, E.,
Seffer, E.,
Mushack, J.,
Ermel, B.,
and Haring, H. U.
(1991)
Biochem. J.
276,
103-108
|
| 17.
|
Krupinski, J.,
Rajaram, R.,
Lakonishok, M.,
Benovic, J. L.,
and Cerione, R. A.
(1988)
J. Biol. Chem.
263,
12333-12341[Abstract/Free Full Text]
|
| 18.
|
Okamoto, T.,
Okamoto, T.,
Murayama, Y.,
Hayashi, Y.,
Ogata, E.,
and Nishimoto, I.
(1994)
FEBS Lett.
340,
292-293[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Sanchez-Margalet, V.,
Gonzalez-Yanes, C.,
Santos-Alvarez, J.,
and Najib, S.
(1999)
Cell Mol. Life Sci.
55,
142-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Moxham, C. M.,
and Malbon, C. C.
(1996)
Nature
379,
840-844[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Yang, L. J.,
Baffy, G.,
Rhee, S. G.,
Manning, D.,
Hansen, C. A.,
and Williamson, J. R.
(1991)
J. Biol. Chem.
266,
22451-22458[Abstract/Free Full Text]
|
| 22.
|
Yang, L.,
Camoratto, A. M.,
Baffy, G.,
Raj, S.,
Manning, D. R.,
and Williamson, J. R.
(1993)
J. Biol. Chem.
268,
3739-3746[Abstract/Free Full Text]
|
| 23.
|
Liang, M. N.,
and Garrison, J. C.
(1991)
J. Biol. Chem.
266,
13342-13349[Abstract/Free Full Text]
|
| 24.
|
Ramirez, I.,
Tebar, F.,
Grau, M.,
and Soley, M.
(1995)
Cell Signal.
7,
303-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Church, J. G.,
and Buick, R. N.
(1988)
J. Biol. Chem.
263,
4242-4246[Abstract/Free Full Text]
|
| 26.
|
Piiper, A.,
Stryjek-Kaminska, D.,
and Zeuzem, S.
(1997)
Am. J. Physiol
272,
G1276-G1284[Abstract/Free Full Text]
|
| 27.
|
Tebar, F.,
Ramirez, I.,
and Soley, M.
(1993)
J. Biol. Chem.
268,
17199-17204[Abstract/Free Full Text]
|
| 28.
|
Rubin, R.,
and Baserga, R.
(1995)
Lab. Invest.
73,
311-331[Medline]
[Order article via Infotrieve]
|
| 29.
|
LeRoith, D.,
Werner, H.,
Beitner-Johnson, D.,
and Roberts, C. T., Jr.
(1995)
Endocr. Rev.
16,
143-163[Abstract/Free Full Text]
|
| 30.
|
Kanzaki, M.,
Nie, L.,
Shibata, H.,
and Kojima, I.
(1997)
J. Biol. Chem.
272,
4964-4969[Abstract/Free Full Text]
|
| 31.
|
Luttrell, L. M.,
van Biesen, T.,
Hawes, B. E.,
Koch, W. J.,
Touhara, K.,
and Lefkowitz, R. J.
(1995)
J. Biol. Chem.
270,
16495-16498[Abstract/Free Full Text]
|
| 32.
|
Poiraudeau, S.,
Lieberherr, M.,
Kergosie, N.,
and Corvol, M. T.
(1997)
J. Cell. Biochem.
64,
414-422[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Sarbassov, D. D.,
Jones, L. G.,
and Peterson, C. A.
(1997)
Mol. Endocrinol.
11,
2038-2047[Abstract/Free Full Text]
|
| 34.
|
Uehara, T.,
Tokumitsu, Y.,
and Nomura, Y.
(1999)
Eur. J. Biochem.
259,
801-808[Medline]
[Order article via Infotrieve]
|
| 35.
|
Jin, G. F.,
Guo, Y. S.,
Ball, C.,
and Houston, C. W.
(1993)
Regul. Pept.
49,
125-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Siebler, T.,
Kiess, W.,
Linder, B.,
Kessler, U.,
Schwarz, H. P.,
and Nissley, S. P.
(1996)
Regul. Pept.
62,
65-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Langlois, D.,
Hinsch, K. D.,
Saez, J. M.,
and Begeot, M.
(1990)
Endocrinology
126,
1867-1872[Abstract/Free Full Text]
|
| 38.
|
Linder, B.,
Harris, S.,
Eisen, A.,
and Nissley, P.
(1994)
Mol. Cell. Endocrinol.
105,
111-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Stracke, M. L.,
Kohn, E. C.,
Aznavoorian, S. A.,
Wilson, L. L.,
Salomon, D.,
Krutzsch, H. C.,
Liotta, L. A.,
and Schiffmann, E.
(1988)
Biochem. Biophys. Res. Commun.
153,
1076-1083[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Sell, C.,
Rubini, M.,
Rubin, R.,
Liu, J. P.,
Efstratiadis, A.,
and Baserga, R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11217-11221[Abstract/Free Full Text]
|
| 41.
|
Sell, C.,
Dumenil, G.,
Deveaud, C.,
Miura, M.,
Coppola, D.,
DeAngelis, T.,
Rubin, R.,
Efstratiadis, A.,
and Baserga, R.
(1994)
Mol. Cell. Biol.
14,
3604-3612[Abstract/Free Full Text]
|
| 42.
|
Zhang, F. X.,
Rubin, R.,
and Rooney, T. A.
(1998)
J. Neurochem.
71,
196-204[Medline]
[Order article via Infotrieve]
|
| 43.
|
Zhang, F. X.,
Rubin, R.,
and Rooney, T. A.
(1998)
J. Biol. Chem.
273,
26596-26602[Abstract/Free Full Text]
|
| 44.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Yamauchi, K.,
and Pessin, J. E.
(1994)
Mol. Cell. Biol.
14,
4427-4434[Abstract/Free Full Text]
|
| 46.
|
Yamauchi, K.,
and Pessin, J. E.
(1994)
J. Biol. Chem.
269,
31107-31114[Abstract/Free Full Text]
|
| 47.
|
Dudek, H.,
Datta, S. R.,
Franke, T. F.,
Birnbaum, M. J.,
Yao, R.,
Cooper, G. M.,
Segal, R. A.,
Kaplan, D. R.,
and Greenberg, M. E.
(1997)
Science
275,
661-665[Abstract/Free Full Text]
|
| 48.
|
Kulik, G.,
Klippel, A.,
and Weber, M. J.
(1997)
Mol. Cell. Biol.
17,
1595-1606[Abstract]
|
| 49.
|
del Peso, L.,
Gonzalez-Garcia, M.,
Page, C.,
Herrera, R.,
and Nunez, G.
(1997)
Science
278,
687-689[Abstract/Free Full Text]
|
| 50.
|
Baserga, R.,
Hongo, A.,
Rubini, M.,
Prisco, M.,
and Valentinis, B.
(1997)
Biochim. Biophys. Acta
1332,
F105-F126[Medline]
[Order article via Infotrieve]
|
| 51.
|
Liu, J. L.,
Blakesley, V. A.,
Gutkind, J. S.,
and LeRoith, D.
(1997)
J. Biol. Chem.
272,
29438-29441[Abstract/Free Full Text]
|
| 52.
|
D'Mello, S. R.,
Galli, C.,
Ciotti, T.,
and Calissano, P.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10989-10993[Abstract/Free Full Text]
|
| 53.
|
Luttrell, L.,
Kilgour, E.,
Larner, J.,
and Romero, G.
(1990)
J. Biol. Chem.
265,
16873-16879[Abstract/Free Full Text]
|
| 54.
|
Gawler, D.,
and Houslay, M. D.
(1987)
FEBS Lett.
216,
94-98[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Pyne, N. J.,
Heyworth, C. M.,
Balfour, N. W.,
and Houslay, M. D.
(1989)
Biochem. Biophys. Res. Commun.
165,
251-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Rothenberg, P. L.,
and Kahn, C. R.
(1988)
J. Biol. Chem.
263,
15546-15552[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. X.-D. Song, Z. Zhang, Y. Chen, Y. Bao, and R. J. Santen
Estrogen Signaling via a Linear Pathway Involving Insulin-Like Growth Factor I Receptor, Matrix Metalloproteinases, and Epidermal Growth Factor Receptor to Activate Mitogen-Activated Protein Kinase in MCF-7 Breast Cancer Cells
Endocrinology,
August 1, 2007;
148(8):
4091 - 4101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. El-Shewy, K. R. Johnson, M.-H. Lee, A. A. Jaffa, L. M. Obeid, and L. M. Luttrell
Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors
J. Biol. Chem.,
October 20, 2006;
281(42):
31399 - 31407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Akekawatchai, J. D. Holland, M. Kochetkova, J. C. Wallace, and S. R. McColl
Transactivation of CXCR4 by the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Human MDA-MB-231 Breast Cancer Epithelial Cells
J. Biol. Chem.,
December 2, 2005;
280(48):
39701 - 39708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. T. Wu and Y. H. Wong
Involvement of Gi/o Proteins in Nerve Growth Factor-Stimulated Phosphorylation and Degradation of Tuberin in PC-12 Cells and Cortical Neurons
Mol. Pharmacol.,
April 1, 2005;
67(4):
1195 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Patel
Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades
Pharmacol. Rev.,
September 1, 2004;
56(3):
371 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ibarra, M. Estrada, L. Carrasco, M. Chiong, J. L. Liberona, C. Cardenas, G. Diaz-Araya, E. Jaimovich, and S. Lavandero
Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes
J. Biol. Chem.,
February 27, 2004;
279(9):
7554 - 7565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Orr, C. E. Pedraza, M. A. Pallero, C. A. Elzie, S. Goicoechea, D. K. Strickland, and J. E. Murphy-Ullrich
Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly
J. Cell Biol.,
June 23, 2003;
161(6):
1179 - 1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Wan, B. S. Sambi, R. Tate, C. Waters, and N. J. Pyne
The Inhibitory gamma Subunit of the Type 6 Retinal cGMP Phosphodiesterase Functions to Link c-Src and G-protein-coupled Receptor Kinase 2 in a Signaling Unit That Regulates p42/p44 Mitogen-activated Protein Kinase by Epidermal Growth Factor
J. Biol. Chem.,
May 9, 2003;
278(20):
18658 - 18663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang and X. J. Liu
A G Protein-coupled Receptor Kinase Induces Xenopus Oocyte Maturation
J. Biol. Chem.,
April 25, 2003;
278(18):
15809 - 15814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Waters, B. Sambi, K.-C. Kong, D. Thompson, S. M. Pitson, S. Pyne, and N. J. Pyne
Sphingosine 1-Phosphate and Platelet-derived Growth Factor (PDGF) Act via PDGFbeta Receptor-Sphingosine 1-Phosphate Receptor Complexes in Airway Smooth Muscle Cells
J. Biol. Chem.,
February 14, 2003;
278(8):
6282 - 6290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Booth, C. Cummings, M. Tiberi, and X. J. Liu
GIPC Participates in G Protein Signaling Downstream of Insulin-like Growth Factor 1 Receptor
J. Biol. Chem.,
February 15, 2002;
277(8):
6719 - 6725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tao, C. C. Malbon, and H.-y. Wang
Galpha i2 Enhances Insulin Signaling via Suppression of Protein-tyrosine Phosphatase 1B
J. Biol. Chem.,
October 19, 2001;
276(43):
39705 - 39712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Faivre, K. Regnauld, E. Bruyneel, Q.-D. Nguyen, M. Mareel, S. Emami, and C. Gespach
Suppression of Cellular Invasion by Activated G-Protein Subunits Galpha o, Galpha i1, Galpha i2, and Galpha i3 and Sequestration of Gbeta gamma
Mol. Pharmacol.,
August 1, 2001;
60(2):
363 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Boney, H. Sekimoto, P. A. Gruppuso, and A. R. Frackelton Jr.
Src Family Tyrosine Kinases Participate in Insulin-like Growth Factor I Mitogenic Signaling in 3T3-L1 Cells
Cell Growth Differ.,
July 1, 2001;
12(7):
379 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rakhit, S. Pyne, and N. J. Pyne
Nerve Growth Factor Stimulation of p42/p44 Mitogen-Activated Protein Kinase in PC12 Cells: Role of Gi/o, G Protein-Coupled Receptor Kinase 2, beta -Arrestin I, and Endocytic Processing
Mol. Pharmacol.,
July 1, 2001;
60(1):
63 - 70.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Rakhit, S. Pyne, and N. J. Pyne
The Platelet-Derived Growth Factor Receptor Stimulation of p42/p44 Mitogen-Activated Protein Kinase in Airway Smooth Muscle Involves a G-Protein-Mediated Tyrosine Phosphorylation of Gab1
Mol. Pharmacol.,
August 1, 2000;
58(2):
413 - 420.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. I. Krieger-Brauer, P. Medda, and H. Kather
Basic Fibroblast Growth Factor Utilizes Both Types of Component Subunits of Gs for Dual Signaling in Human Adipocytes. STIMULATION OF ADENYLYL CYCLASE VIA Galpha s AND INHIBITION OF NADPH OXIDASE BY Gbeta gamma s
J. Biol. Chem.,
November 10, 2000;
275(46):
35920 - 35925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Roudabush, K. L. Pierce, S. Maudsley, K. D. Khan, and L. M. Luttrell
Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells
J. Biol. Chem.,
July 14, 2000;
275(29):
22583 - 22589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guillard, S. Chretien, R. Jockers, S. Fichelson, P. Mayeux, and V. Duprez
Coupling of Heterotrimeric Gi Proteins to the Erythropoietin Receptor
J. Biol. Chem.,
January 12, 2001;
276(3):
2007 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Kuemmerle and K. S. Murthy
Coupling of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase to Gi2 in Human Intestinal Smooth Muscle. Gbeta gamma -DEPENDENT MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION AND GROWTH
J. Biol. Chem.,
March 2, 2001;
276(10):
7187 - 7194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Alderton, S. Rakhit, K. C. Kong, T. Palmer, B. Sambi, S. Pyne, and N. J. Pyne
Tethering of the Platelet-derived Growth Factor beta Receptor to G-protein-coupled Receptors. A NOVEL PLATFORM FOR INTEGRATIVE SIGNALING BY THESE RECEPTOR CLASSES IN MAMMALIAN CELLS
J. Biol. Chem.,
July 20, 2001;
276(30):
28578 - 28585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Wan, B. S. Sambi, M. Frame, R. Tate, and N. J. Pyne
The Inhibitory gamma Subunit of the Type 6 Retinal Cyclic Guanosine Monophosphate Phosphodiesterase Is a Novel Intermediate Regulating p42/p44 Mitogen-activated Protein Kinase Signaling in Human Embryonic Kidney 293 Cells
J. Biol. Chem.,
October 5, 2001;
276(41):
37802 - 37808.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|